This is the public record behind the artifact: what changed, what another person can reuse, what supports the system, and what the build is not entitled to claim.
Inventoried composition, labeling, product-quality, interaction, effect and comparison claims across every public surface.
Kept every product, name, format and relative band fictional and visibly unverified.
Added an explicit COA boundary and prohibited equivalence, safety, dose, therapeutic, purchase and recommendation inference.
Treat names, formats and declared bands as fields—not findings.
Keep actual identity, composition, batch testing, other ingredients, contaminants, label accuracy, interactions, law and person context unknown.
A future COA must be scoped and authenticated; it is not self-validating or proof of safety.
FDA supports CBD-specific uncertainty, quality concerns and unproven-claim boundaries.
CDC supports edible-specific poisoning and label-accuracy context.
Neither validates fictional bands, all cannabis products, a product comparison or a recommendation.
No real product, batch, person, dose, laboratory result, law or COA is represented.
No strain-name equivalence, identity, composition, interaction, effect, quality, safety, legality, therapeutic, purchase or recommendation inference is permitted.
Any future COA requires issuer, method, sample-to-batch match, analyte panel, detection limits, date and chain-of-custody review and still does not prove safety or suitability.
FDA — Cannabis/CBD consumer update →
Exact locator: Introductory bullets; Unanswered questions about science, safety and quality; Unproven medical claims and unsafe manufacturing practices; retrieved 2026-08-23. Scope limit: CBD-focused uncertainty and documented quality concerns only; not a universal product, dose, effect, safety or recommendation source.
CDC — Cannabis and Poisoning →
Exact locator: Key points; Effects of edible cannabis; retrieved 2026-08-23. Scope limit: Edible-specific poisoning and label-accuracy context only; not identity, composition, quality or risk evidence for every product.
VISUAL ASSET REVIEW
The creator-owned cover remains live unless every external-candidate gate is explicitly complete. Disabled controls report canonical status; they do not imply an approval action occurred here.
Status: Release-eligible fallback
Credit: © RN Collins · RN Builds
Use the complete 720×900 frame. Do not crop the build number, headline, safe margins or boundary language.
This creator-owned opening frame supports only the visible build proposition and build identity. It is not documentary evidence and does not establish institutional endorsement, lived experience, product performance, safety, compliance, effectiveness, causation, community authority or outcome.
Disposition: HOLD
HOLD — primary-source terms reviewed; no exact asset-level authorization established.
Orientation/dimensions: ; × .
Crop: Not applicable until an exact asset is selected and its integrity and rights are verified.
Alt text:
Credit: Source-page issuer: U.S. Food and Drug Administration; asset credit unresolved because no asset is selected.
Claim boundary: The official page is relevant context only. It does not make an unspecified image evidence of the build, its outcomes, safety, compliance, effectiveness, or endorsement.
EXTERNAL SOURCE REVIEW · HOLD · NOT SELECTED · NOT STAGED
Classification: NO EXACT SOURCE
HOLD — primary-source terms reviewed; no exact asset-level authorization established.
Open authoritative context source →
Capture status: NOT APPLICABLE — NO EXACT ASSET
Attribution: Source-page issuer: U.S. Food and Drug Administration; asset credit unresolved because no asset is selected.
Alt text: Review record for U.S. Food and Drug Administration + Centers for Disease Control and Prevention + Hawai‘i State Department of Health in relation to Build 052, Synthetic Cannabis Comparison Literacy. No external asset is selected or staged.
Caption: Official-source context reviewed for Build 052; external visual remains on HOLD.
Claim boundary: The official page is relevant context only. It does not make an unspecified image evidence of the build, its outcomes, safety, compliance, effectiveness, or endorsement.
Fallback decision: Retain the original RN cover. No external promotion is authorized.
ORIGINAL RN FALLBACK • HOLD • NOT EVIDENCE
Original RN-created fallback diagram for Build 052, “The Label Becomes One Field.” It illustrates the build concept and is not evidence of external validation, performance, compliance or endorsement.
This generated RN-owned fallback is available for review while the third-party candidate remains on HOLD. It is not selected external evidence and does not change staging status.
Open the full fallback SVG → · Download SVG ↓
SHA-256: 29df687042b1ba08eb876f0720eaf8cfa4be823569004ccefb2946f9b3072284
Dimensions: 1200 × 1500; image/svg+xml; 2186 bytes.
CANONICAL SEVEN-SLIDE PRODUCTION BLUEPRINT
Cover: Open exact mapped asset →
Use the complete RN-owned cover at /media/builds/052/build-052-linkedin-poster.png. Do not crop text, credits, safe margins, or claim boundary.
Claim boundary: This creator-owned opening frame supports only the visible build proposition and build identity. It is not documentary evidence and does not establish institutional endorsement, lived experience, product performance, safety, compliance, effectiveness, causation, community authority or outcome.
Accessibility: Slide 1 alt text must identify Build 052, the hook function, essential visible text, and the information conveyed by the visual. Keep reading order headline → visual → boundary/credit.
Rights: Creator-owned production asset; no third-party visual identified or implied.
RN-owned problem framing: isolate the tension behind “A NAME IS NOT A VERIFIED PRODUCT RECORD. A familiar label does not supply verified identity, composition, quality, effect or safety.”. Use typography plus one simple contrast or decision fork; no stock people.
Claim boundary: RN synthesis only; avoid performance, compliance, safety, effectiveness, causal, testimonial, or endorsement claims.
Accessibility: Slide 2 alt text must identify Build 052, the problem function, essential visible text, and the information conveyed by the visual. Keep reading order headline → visual → boundary/credit.
Rights: Use RN-owned typography, diagrams, and verified prototype captures only.
Show an RN-owned diagram or prototype view of the Synthetic Cannabis Comparison Literacy mechanism. Label inputs, decision/action, and output; do not depict outcomes not present in the build.
Claim boundary: RN synthesis only; avoid performance, compliance, safety, effectiveness, causal, testimonial, or endorsement claims.
Accessibility: Slide 3 alt text must identify Build 052, the system function, essential visible text, and the information conveyed by the visual. Keep reading order headline → visual → boundary/credit.
Rights: Use RN-owned typography, diagrams, and verified prototype captures only.
Use an RN-owned evidence-boundary card. The recognizable entity “U.S. Food and Drug Administration + Centers for Disease Control and Prevention + Hawai‘i State Department of Health” may be named as context only; do not use its marks, screenshots, portraits, or trade dress.
Claim boundary: The official page is relevant context only. It does not make an unspecified image evidence of the build, its outcomes, safety, compliance, effectiveness, or endorsement.
Accessibility: Slide 4 alt text must identify Build 052, the evidence function, essential visible text, and the information conveyed by the visual. Keep reading order headline → visual → boundary/credit.
Rights: RN-owned design only; contextual source: https://www.fda.gov/consumers/consumer-updates/what-you-need-know-and-what-were-working-find-out-about-products-containing-cannabis-or-cannabis; no third-party visual authorized.
Use an authentic RN prototype/interface capture from Build 052, or a faithful RN-owned diagram if no stable interface view exists. Clearly label simulated, fictional, or illustrative states.
Claim boundary: Show only an observed prototype state; label simulation and fiction; do not imply deployment or outcome.
Accessibility: Slide 5 alt text must identify Build 052, the demo function, essential visible text, and the information conveyed by the visual. Keep reading order headline → visual → boundary/credit.
Rights: Use RN-owned typography, diagrams, and verified prototype captures only.
Use a two-column RN synthesis: what this build makes possible / what it does not establish. No universal, causal, safety, compliance, or effectiveness claim.
Claim boundary: RN synthesis only; avoid performance, compliance, safety, effectiveness, causal, testimonial, or endorsement claims.
Accessibility: Slide 6 alt text must identify Build 052, the implications function, essential visible text, and the information conveyed by the visual. Keep reading order headline → visual → boundary/credit.
Rights: Use RN-owned typography, diagrams, and verified prototype captures only.
Use a quiet RN-owned closing card with Build 052, the canonical dossier URL, CTA, source/credit line, and “RN synthesis · no endorsement” where an institution is named.
Claim boundary: RN synthesis only; avoid performance, compliance, safety, effectiveness, causal, testimonial, or endorsement claims.
Accessibility: Slide 7 alt text must identify Build 052, the cta + sources function, essential visible text, and the information conveyed by the visual. Keep reading order headline → visual → boundary/credit.
Rights: Use RN-owned typography, diagrams, and verified prototype captures only.
Instagram: Publish all seven 4:5 slides; keep credits and boundaries on-slide; write the supplied alt text manually.
LinkedIn: Export as an accessible seven-page PDF; preserve live links in the post copy and use the build dossier as the canonical source.
Reels/TikTok: Animate slides 1–6 as silent-first vertical beats; retain captions, visible source credit, and final CTA; do not imply motion footage is documentary.
Web/newsletter: Use slide 1 as the preview and embed/link the dossier; do not detach the source-context image from its caption, credit, and limitation.
Download all 100 structured blueprints ↓ · Read production instructions →
All seven accessible 1200×1500 slides for this build are generated and included in the deterministic distribution packages. Metadata retains exact alt text, visual guidance, credit, source, rights, and claim boundaries.
Open carousel asset operations → · Open 700-slide inventory → · Read import instructions →
Download this build’s Canva batch ↓ · Download Instagram package ↓ · Download LinkedIn package ↓
This build’s current cover and complete metadata are included in the deterministic 100-cover handoff. The package preserves this dossier’s official/RN decision, source, rights, claim boundary, and rollback state.
Download the complete Canva-ready ZIP ↓ · Open package inventory → · Read import instructions →
A public build record has four sections and they are ordered on purpose. Making is the narrative of what changed, written so that someone who was not there can follow the decisions in sequence. Method is the part meant to travel: the rules and structures another person could apply to a different problem in a different field. Evidence is what supports the system, stated as specifically as the underlying material allows. Limits close the record because they determine how far everything above them can be carried.
The reason limits come last is that they are the part most often left out, and a record without them is a marketing page with citations. Every claim in the sections above is bounded by what the final section says, and a reader who skips it will overstate what the build establishes. If you only have time for two sections, read Method and Limits: together they tell you what you could reuse and how far you could trust it.
Where external sources appear, each is given with an exact locator rather than a bare link, so the specific passage relied on can be checked instead of the whole document. A scope limit accompanies each one. That limit describes what the source was used for in this build, which is frequently narrower than what the source as a whole covers, and quoting the source for a broader claim than the scope allows would be a misuse of it even though the link resolves.
Language here is chosen to hold up under scrutiny rather than to sound confident. Where a review is complete, the record says so and names what the review covered. Where a review remains open, the record says that instead, and continues to say it until the work is done. A statement that something is a demonstration, a synthetic fixture or an unverified claim is a factual description of that artifact, and it stays on the page because removing it would make the surrounding claims read as stronger than the evidence supports.
Finally, this record documents one build among a hundred that are designed to inherit from each other. What Method describes is often the thing a later build depends on, so a record is worth reading alongside the lineage view rather than purely on its own. That is where the capability described here can be traced forward into whatever was built on top of it.
